Skip to main content

For updates and guidance related to COVID-19 / Coronavirus, click here.

Justin Acosta Comment On Regulatory Notice 21-19

Justin Acosta
Medical

The technology is available for T+0, we are fighting with companies who have the whole picture, yet we retail investors have to wait two days. We need more transparency, along with detailed rule enforcement, but overall we need more transparency, the retail investor knows that the tables are tilted towards the large institution. It is an unfair advantage.